The Qatar Investment Authority has backed a new $200 million fund by Shorooq Partners, aiming to inject institutional capital into the region's mature startups and bridge a critical funding hurdle on the path to public listings.
Fueled by new funding and AI-powered tools, the Internal Revenue Service is intensifying its scrutiny of gig economy and freelance income, making even small earnings reportable. Here’s what you need to know to stay compliant.
In Zimbabwe, where formal employment is scarce and medical costs are prohibitive, a stark financial choice is being made: affordable funeral policies are vastly outpacing health insurance, reflecting a cultural prioritization of dignified burials over accessible healthcare.
Virgin Galactic's shares have cratered to near $3, presenting a stark dilemma for investors. While a traditional valuation model suggests a staggering 95% discount, the market's skepticism reflects deep-seated concerns over the company's path to profitability in the nascent space tourism sector.
A five-year-old boy and his father are back in Minnesota following their release from a Texas immigration detention facility, a case a federal judge called the result of an 'ill-conceived' pursuit of deportation quotas that traumatizes children.
Kofi Ampadu, the partner who led a16z's Talent x Opportunity fund, has left the firm months after the program was paused indefinitely, signaling a potential retreat from structured DEI efforts in venture capital.
A wave of protests and student walkouts swept across the United States on Friday, demanding the withdrawal of federal immigration agents from Minnesota following fatal shootings, as political tensions threaten a government shutdown.
After a November dip, Texas's upstream oil and gas sector added 2,000 jobs in December, contributing to the state's record-breaking employment figures and underscoring the industry's pivotal role in the Texan economy and tax base.
Analysts have pinned high hopes on several names, but a closer look reveals a more nuanced picture. We examine one company likely to justify the optimism and two where significant risks may be overshadowing the bullish price targets.
Pharmaceutical leader Eli Lilly will build a new manufacturing facility in Lehigh County, marking the largest life sciences investment in Pennsylvania history and bolstering U.S. production of next-generation weight-loss drugs.
French biopharma firm Inventiva (ENXTPA:IVA) has delivered a stunning 126% total return to shareholders over the past year, sharply contrasting with losses over a three-year horizon. As the stock experiences short-term pullbacks, analysts debate whether its current €5.23 price reflects future promise or present hype, with a key drug candidate hanging in the balance.
A couple earning $380,000 annually faces a classic high-cost dilemma: Should they stretch for a $1.8 million dream home now or wait? With a hefty down payment saved but significant student debt, their debate highlights the tension between future earnings potential and present financial anxiety in today's premium housing markets.
Thousands of Shiite Muslims who fled Syria following the 2024 fall of the Assad government have settled into a newly opened housing compound in northeastern Lebanon, funded by Shiite institutions and Hezbollah, offering a permanent solution after years of temporary shelter.
Three years after securing $1.3 billion in state incentives, Volkswagen-backed Scout Motors' planned electric vehicle factory faces mounting public costs amid wetland mitigation and inflation, raising questions about risk allocation.
United Natural Foods, Inc. launches a landmark grant program across all 50 U.S. states and Canada to celebrate its 50th year, even as its stock performance presents a mixed picture for value-focused investors.
Official figures reveal a sharp 26% increase in the annual cost of public sector pensions, now reaching £39bn, with taxpayers covering the bulk of the expense as employer contribution rates rise.
Major U.S. federal investment to build a domestic rare earth supply chain emerges as a direct competitive threat to Lynas Rare Earths, coinciding with the planned retirement of its long-serving CEO Amanda Lacaze. The developments test the Australian miner's strategic position in a market defined by geopolitical tensions and supply security concerns.
In a strategic move to unify its product and technology vision, Netflix has elevated CTO Elizabeth Stone to the newly created role of Chief Product and Technology Officer. The promotion places her at the helm of the streaming giant's core product, engineering, and data divisions.
UPS's ambitious free cash flow target for 2026 appears to secure its hefty dividend, but a closer look reveals reliance on asset sales, deep cost cuts, and reduced capital investment—a strategy that may be mortgaging its long-term expansion.
Novo Nordisk launches its first oral GLP-1 weight-loss drug with strong early demand, reports positive Phase 3 results for CagriSema, and expands a cell therapy partnership for diabetes. These moves come as investors reevaluate the company's long-term growth prospects amid competitive and pricing pressures.
